Phase II evaluation of interferon-alpha-2a for progressive or recurrent craniopharyngiomas.
Jakacki, R I⋅Cohen, B H⋅Jamison, C⋅Mathews, V P⋅Arenson, E⋅Longee, D C⋅Hilden, J⋅Cornelius, A⋅Needle, M⋅Heilman, D⋅Boaz, Joel C and Luerssen, T G
Journal of neurosurgery, vol. 92, (no. 2), pp. 255-60, 2000/Feb. | Journal Article